Zurcher Kantonalbank »

Rani Therapeutics Hldgs shares owned by Zurcher Kantonalbank

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Zurcher Kantonalbank from 13F filings

Historical chart of Zurcher Kantonalbank investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Zurcher Kantonalbank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Zurcher Kantonalbank

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.7k 11k 0.73

More positions owned by Zurcher Kantonalbank

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ubs Group SHS (UBS)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alcon Ord Shs (ALC)
Eli Lilly & Co. (LLY)
Amrize SHS (AMRZ)
JPMorgan Chase & Co. (JPM)
Wal-Mart Stores (WMT)

View all positions for Zurcher Kantonalbank

Top funds holding Rani Therapeutics Hldgs

RA Capital Management
Samsara BioCapital
AWM Investment Company
Vanguard Group
Vanguard Capital Management
SymBiosis Capital Partners
Longaeva Partners
Susquehanna International
Siren
Geode Capital Management
BlackRock
Nan Fung Group Holdings
683 Capital Management
Vanguard Fiduciary Trust
Millennium Management

View all funds holding Rani Therapeutics Hldgs